Anteris Technologies Ltd (ASX:AVR)


right-arrow Created with Sketch. -0.8 (-8%)
MCAP $80.78M
Last trade 16.10pm 26/11/2021 20mins delayed

Latest Announcements

26/11/2021AVRAnteris Technologies Ltd
24/11/2021AVRAnteris Technologies Ltd
22/11/2021AVRAnteris Technologies Ltd
22/11/2021AVRAnteris Technologies Ltd
22/11/2021 Price SensitivePSAVRAnteris Technologies Ltd
17/11/2021AVRAnteris Technologies Ltd
16/11/2021AVRAnteris Technologies Ltd
15/11/2021AVRAnteris Technologies Ltd

Company Overview

Anteris Technologies Ltd is an Australia-based structural heart company. The Company is engaged in delivering solutions that help healthcare professionals. The Company operates through two segments: operations and projects. Operation segment provides Bio implant ADAPT operations inclusive of manufacturing and sales. Project segment includes Transcatheter Aortic Valve Replacement (TAVR), which is developed using ADAPT 3D single-piece technology and other development projects across the Company. It offers two products, ADAPT and DurAVR. ADAPT technology is a BioScaffold, which is a tissue technology platform that demonstrates zero calcification. xenograft tissue into a pure collagen scaffold with optimized strength and pliability, biocompatibility and unparalleled durability. DurAVR heart valve Is focused on delivering a functional cure in the treatment of Severe Aortic Stenosis.

AVR in the news

Anteris Technologies (AVR) implants five TAVR patients in a first-in-human study to…
Anteris Technologies (AVR) places 625,000 new ordinary shares to Melbourne-based global investor…
Anteris Technologies (AVR) pauses trading as it plans for an upcoming capital…
Anteris Technologies (AVR) has finished its proof of concept animal study on…

Search Previous Announcements